-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2026
置信度 0.74
-
crossref
2026-04-23T21:11:07Z
置信度 0.70
-
crossref
Aarif Ali, Javeed Iqbal Ahmad Bhat, Farheen Shafique
2025-07-04T10:41:22Z
置信度 0.70
-
crossref
2025-03-18T08:20:27Z
置信度 0.70
-
crossref
2025-03-18T08:20:27Z
置信度 0.70
-
crossref
Vijay Sheri, Baohong Zhang
2025-05-22T07:43:58Z
置信度 0.70
-
crossref
2026-04-23T21:11:07Z
置信度 0.70
-
crossref
Ewen Callaway
2017-08-31T19:56:11Z
置信度 0.70
-
crossref
2024-05-31T20:05:46Z
置信度 0.70
-
crossref
2024-05-31T20:08:33Z
置信度 0.70
-
crossref
Vicente Beliver, Federico de Montalvo
2021-12-15T16:42:46Z
置信度 0.70
-
crossref
2024-02-22T12:00:14Z
置信度 0.70
-
In February 2025, a six-month-old infant became the first person to receive a personalized CRISPR gene-editing therapy, demonstrating both what is possible and what is missing. Current US regulatory infrastructure treats every personalized gene-editing therapy…
crossref
Jeff Coller, Sadik H. Kassim
2026-07-29T13:52:04Z
置信度 0.70
-
crossref
2019-10-15T09:05:01Z
置信度 0.70
-
crossref
Francesco Niola, Frederik Dagnæs-Hansen, Morten Frödin
2019-03-25T09:03:05Z
置信度 0.70
-
crossref
2025-12-23T10:01:07Z
置信度 0.70
-
crossref
2019-06-25T13:25:55Z
置信度 0.70
-
The CRISPR/Cas system is a powerful tool for both scientific research and potential therapeutic strategies for inherited diseases. This PhD thesis investigated the feasibility of cell-penetrating peptide-mediated direct delivery of CRISPR/Cas components to ach…
crossref
Mert Öktem
2024-08-21T19:14:24Z
置信度 0.70
-
crossref
Michaela Bruntraeger, Meg Byrne, Kathleen Long, Andrew R. Bassett
2019-03-25T09:03:05Z
置信度 0.70
-
crossref
2025-03-18T08:20:27Z
置信度 0.70
-
crossref
Seher Yerlikaya, Abdullah Aydın, Nisa Nur Yılmaz, Bayram Ali Yerlikaya 等
2026-04-01T14:14:25Z
置信度 0.70
-
crossref
Liangliang Ma, Shanglun Yang, Qianya Peng, Jingping Zhang 等
2023-05-12T11:29:17Z
置信度 0.70
-
crossref
2014-04-08T19:44:10Z
置信度 0.70
-
crossref
Vijai Singh, Darren Braddick, Pawan Kumar Dhar
2016-11-08T22:45:23Z
置信度 0.70
-
crossref
Shakeel Ahmad, Asif Ali Khan, Muhammad Arshad Javed
2025-04-01T15:32:44Z
置信度 0.70
-
crossref
Magdalena Klimek-Chodacka, Tomasz Oleszkiewicz, Rafal Baranski
2019-01-04T17:14:42Z
置信度 0.70
-
crossref
2022-11-04T11:15:00Z
置信度 0.70
-
crossref
Dr.Jennifer A Domm
2026-08-28T07:10:15Z
置信度 0.70
-
crossref
2020-03-03T11:57:22Z
置信度 0.70
-
crossref
2020-04-06T09:09:12Z
置信度 0.70
-
crossref
2019-06-25T13:25:55Z
置信度 0.70
-
The piggyBac transposon system can be combined with CRISPR/Cas9 to efficiently perform genetic manipulations in animal models or cells lines, including stem cells, without leaving behind any accessory DNA sequences like for example it happens in the Cre system…
crossref
Patrick Ovando-Roche
2021-08-19T18:20:31Z
置信度 0.70
-
crossref
Cole Sims
2020-11-02T16:45:08Z
置信度 0.70
-
crossref
2025-07-31T18:33:37Z
置信度 0.70
-
crossref
2026-05-22T19:41:03Z
置信度 0.70
-
crossref
2025-03-18T08:20:27Z
置信度 0.70
-
crossref
2021-12-15T16:01:14Z
置信度 0.70
-
The ability to edit genes with CRISPR has, in a few short years, been transformative to genetics, generating follow-on science such as drought-resistant crops and mosquitos that cannot carry malaria, and is widely expected to win a Nobel prize. The rush of sci…
crossref
Neil Thompson, Samantha Zyontz
2017-12-06T11:02:01Z
置信度 0.70
-
crossref
2021-12-15T16:01:14Z
置信度 0.70
-
crossref
Nayla Munawar, Aftab Ahmad
2025-05-22T07:43:58Z
置信度 0.70
-
crossref
Kathy Clara Bui, Daichi Kamiyama
2023-04-21T20:50:08Z
置信度 0.70
-
CRISPR gene editing is a molecular technology that can be used to silence gene expression. In this experiment, genes that are known to play a role in lipid accumulation in hepatocytes were targeted. Specifically, levels of fatty acid transport proteins 2 and 5…
crossref
Erin Young, Cem Kuscu, Christine Watkins, Murat Dogan
2022-01-21T15:48:52Z
置信度 0.70
-
crossref
Lisbeth Ahm Hansen, Ernst-Martin Füchtbauer
2019-03-25T13:03:05Z
置信度 0.70
-
crossref
2019-03-25T09:03:05Z
置信度 0.70
-
crossref
Maria Pallarès Masmitjà, Nastassia Knödlseder, Marc Güell
2019-03-25T09:03:05Z
置信度 0.70
-
Inherited retinal dystrophies (IRDs) are a heterogeneous group of diseases that affect more than 2 million people worldwide. Gene therapy (GT) has emerged as an exciting treatment modality with the potential to provide long-term benefit to patients. Today, gen…
crossref
Juliette Pulman, José-Alain Sahel, Deniz Dalkara
2022-05-04T10:50:27Z
置信度 0.70
-
crossref
Thanaporn Sriyakul, Saquib Ahmed, Bhupinder Singh, Anjali Raghav
2026-06-05T11:29:32Z
置信度 0.70
-
crossref
Hiroaki Kusano, Ami Takeuchi, Hiroaki Shimada
2024-03-18T08:02:35Z
置信度 0.70
-
crossref
Huma Hameed, Muhammad Zaman, Saleha Faheem, Mahtab Ahmad Khan 等
2025-07-04T10:41:22Z
置信度 0.70